Inari Medical Inc expected to post breakeven results a share - Earnings Preview

Inari Medical

31/10/2023 02:05

* Inari Medical Inc  NARI.OQ   NARI.O  is expected to show a
rise
in quarterly revenue when it reports  results 
    * The Irvine California-based  company is expected to report
 a
26.7% increase in revenue to $121.921 million from $96.2 million
a year ago, according to the mean estimate from 9 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Inari Medical Inc
is for
breakeven results per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inari
Medical Inc
is $84.5​, above​ its last closing price of $58.34. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.13       -0.13      0.04      Beat    131.6
 Mar. 31 2023  -0.22       -0.23      -0.04     Beat    82.3
 Dec. 31 2022  -0.17       -0.17      -0.11     Beat    35.8​
 Sep. 30 2022  -0.26       -0.25      -0.19     Beat    25.1
 ​​Jun.        -0.23       -0.23      -0.19     Beat    17.4
 30 2022                                                
 Mar. 31 2022  -0.09       -0.09      -0.06     Beat    34.5​
 Dec. 31 2021  0.06        0.03       0.02      Missed  -23.1
 Sep. 30 2021  -0.21       -0.11      -0.06     Beat    45.5
 This summary was machine generated October 31 at 02:05 GMT.  All
figures in US dollars  unless otherwise stated